Literature DB >> 10234825

Shigella flexneri YSH6000 induces two types of cell death, apoptosis and oncosis, in the differentiated human monoblastic cell line U937.

T Nonaka1, A Kuwae, C Sasakawa, S Imajoh-Ohmi.   

Abstract

Shigella flexneri, but not a non-invasive mutant derivative rapidly induced cell death in human monoblastic U937 cells as well as in differentiated cells pretreated with interferon-gamma (IFN gamma) or retinoic acid (RA). We investigated the morphological and biochemical characteristics of bacterial invasion-induced cell death in these differentiated U937 cells. IFN gamma-differentiated cells showed morphological changes typical of apoptosis and their DNA was cleaved giving a ladder-like electrophoretic pattern after infection by Shigellae. In contrast, swelling of the cytoplasm and blebbing of the plasma membrane were observed in RA-differentiated and undifferentiated cells invaded by the bacteria. No condensation of nuclei was observed in these cells by light microscopy, and no internucleosomal fragmentation of DNA was detected on agarose gels, which resembled the features of oncosis. Furthermore, cleavage of poly(ADP-ribose) polymerase, a substrate for apoptotic caspases, was seen only in IFN gamma-pretreated cells but not in RA-pretreated or undifferentiated cells. These findings suggested that virulent Shigella flexneri induces distinct types of cell death in U937 cells depending on their differentiation state.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10234825     DOI: 10.1111/j.1574-6968.1999.tb13553.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  14 in total

Review 1.  Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells.

Authors:  Susan L Fink; Brad T Cookson
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

2.  Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen.

Authors:  Sacha Lucchini; Hong Liu; Qi Jin; Jay C D Hinton; Jun Yu
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Human Enteric Defensin 5 Promotes Shigella Infection of Macrophages.

Authors:  Dan Xu; Chongbing Liao; Jiu Xiao; Kun Fang; Wei Zhang; Weirong Yuan; Wuyuan Lu
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

Review 4.  The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies.

Authors:  D J Philpott; J D Edgeworth; P J Sansonetti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

5.  Development of in vitro correlate assays of immunity to infection with Yersinia pestis.

Authors:  J Bashaw; S Norris; S Weeks; S Trevino; J J Adamovicz; S Welkos
Journal:  Clin Vaccine Immunol       Date:  2007-03-21

6.  Macrophage cell death upon intracellular bacterial infection.

Authors:  Xin-He Lai; Yunsheng Xu; Xiao-Ming Chen; Yi Ren
Journal:  Macrophage (Houst)       Date:  2015-04-26

7.  Induction of necrosis in human neutrophils by Shigella flexneri requires type III secretion, IpaB and IpaC invasins, and actin polymerization.

Authors:  M François; V Le Cabec; M A Dupont; P J Sansonetti; I Maridonneau-Parini
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Shigella flexneri IpaH(7.8) facilitates escape of virulent bacteria from the endocytic vacuoles of mouse and human macrophages.

Authors:  C M Fernandez-Prada; D L Hoover; B D Tall; A B Hartman; J Kopelowitz; M M Venkatesan
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

9.  Flagella facilitate escape of Salmonella from oncotic macrophages.

Authors:  Gen-ichiro Sano; Yasunari Takada; Shinichi Goto; Kenta Maruyama; Yutaka Shindo; Kotaro Oka; Hidenori Matsui; Koichi Matsuo
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

10.  Macrophage Apoptosis Triggered by IpaD from Shigella flexneri.

Authors:  Olivia Arizmendi; William D Picking; Wendy L Picking
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.